Project Grant HT94252510266

Award Date 5/1/25
Completion Date 4/30/28
Dollars Obligated $872K
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Cleveland, OH 44106, USA
Similar Awards
This federal Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) provides $1,163,218.00 to Case Western Reserve University's Office of Research Administration Division (doing business as University Hospitals of Cleveland) to conduct research on SLC37A3 as a novel prostate cancer target. The award period runs from July 15, 2024 to July 14, 2028. Through this funding, Case Western Reserve University will carry out...
This federal Project Grant award in the amount of $1,071,797.00 was issued by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. The award is focused on investigating the "Effect of Respiratory Muscle Training on Dyspnea and Immunosuppression in Black and White Lung Cancer Survivors" and will be performed by the non-profit organization Health Research, Inc. at their Roswell Park Division facility in Buffalo, NY. The research aims to...
The Department of Defense's Military Medical Research and Development program (CFDA 12.420) awarded Case Western Reserve University's Office of Research Administration Division, doing business as University Hospitals of Cleveland, a $1,467,210 Project Grant on September 30, 2024. The grant supports research to develop a novel dendritic cell therapy approach for mucosal melanoma, focusing on targeting a differentiation epitope in CD11b of tumor-associated inflammatory monocytes. The research aims...
The Department of the Army Medical Command awarded Case Western Reserve University a $1,288,000 Project Grant under the Military Medical Research and Development program (CFDA 12.420). The grant will fund research to therapeutically target superclusters at genes driving childhood sarcoma from September 2021 through September 2025. The Military Medical Research and Development program supports basic, applied, and advanced biomedical research to transform military and public health care through...
The federal Project Grant award of $1,225,245.00, awarded by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program, supports a research initiative titled "CARDIOVASCULAR RISK PROFILING OF DEPLOYMENT-RELATED RESPIRATORY DISEASE: A TRANSLATIONAL APPROACH" at The Ohio State University. The research project aims to investigate cardiovascular risk factors associated with deployment-related respiratory diseases, with the goal of developing...
The Department of the Army Medical Command awarded Case Western Reserve University a $795,901 project grant under the Military Medical Research and Development program (CFDA 12.420). The university will develop a novel agent targeting microglial activation induced by therapeutic brain irradiation over a three year period ending August 31, 2025. Through this funding, the awardee aims to investigate medical solutions for the battlefield and transform health care for service members and the...
The federal Project Grant award of $202,800.00 was provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) federal grant program. The award supports research on "Spatial Copy Number and Morphologic Alterations in Early Lung Carcinogenesis" conducted by the Icahn School of Medicine at Mount Sinai, a prominent academic medical center and research institution located in New York City. The research aims to investigate neural mechanisms and...
The U.S. Department of Defense (DoD) awarded a $497,747 project grant to Case Western Reserve University's Office of Research Administration Division (doing business as University Hospitals of Cleveland) under the Military Medical Research and Development program (CFDA 12.420). The grant supports the development of a novel, central nervous system-penetrant synthetic oleanane triterpenoid for the treatment of diffuse intrinsic pontine glioma (DIPG), a rare and aggressive form of pediatric brain...
This $159,900 federal Project Grant award from the Department of the Army Medical Command under the Military Medical Research and Development (CFDA 12.420) program supports preclinical research on brain metastases in lung cancer. The award will fund studies at the University of Illinois to develop and evaluate novel drug efficacy and resistance models for advancing the treatment of brain metastases, a significant challenge in lung cancer management. Spanning one year from August 2024 to August...
This $779,983 Project Grant from the Department of the Army Medical Command supports the "DUAL-TRACER PET IMAGING TO TRACK LIVER CANCER THERAPY" research being conducted by Case Western Reserve University from August 1, 2022 to July 31, 2025. The grant falls under the Military Medical Research and Development program (CFDA 12.420), which aims to transform military and public health care through innovative biomedical research solutions for battlefield medicine. Case Western will use the...

The federal Project Grant award of $872,237.00 was provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) federal grant program. The grant supports a project titled "Pulmonary Rehabilitation in Advanced Lung Cancer Survivors" to be conducted by Case Western Reserve University's Office of Research Administration. The project aims to conduct advanced biomedical research focused on transforming healthcare for military service members and the broader public, with a particular emphasis on lung cancer and pulmonary conditions. The 3-year project, with a performance period from May 1, 2025 to April 30, 2028, will leverage Case Western Reserve University's robust research capabilities and expertise in areas such as cancer biology, engineering, and healthcare technologies to develop innovative approaches to disease prevention, diagnosis, and treatment.

Generated 5/13/25, 3:37 AM